ArticleCureus2026
Association Between COVID-19 Vaccination, Obesity, and Symptom Burden in a Mexican Population: A Retrospective Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background This study aimed to evaluate the association between the presence of COVID-19 symptomatology (quantified as total self-reported symptom count and validated by medical personnel) and obesity in vaccinated and unvaccinated individuals during the epidemiological period from July to December 2021. Methods A retrospective, cross-sectional epidemiological study was conducted using data from 2,008 adults with laboratory-confirmed SARS-CoV-2 infection identified during COVID-19 detection campaigns in multiple municipalities of Oaxaca, Mexico, between July and December 2021. Data on age, sex, body mass index (BMI) category, vaccination status, vaccine type, and reported symptoms were analyzed. SARS-CoV-2 infection was confirmed by rapid antigen testing followed by reverse transcription polymerase chain reaction (RT-PCR). The primary outcome was the total number of self-reported symptoms at diagnosis. Statistical analysis included descriptive statistics and one-way ANOVA with Tukey post hoc testing (p<0.05). Results Individuals with BMI above normal, particularly those who were unvaccinated and aged over 40 years (age was treated as a stratification variable), reported a higher number of COVID-19 symptoms. Vaccinated patients with elevated BMI showed a lower symptom burden compared with unvaccinated individuals. When analyzed by vaccine type, vaccination with Pfizer-BioNTech (BNT162b2) and CanSinoBio (Ad5-nCoV) was associated with a significantly lower number of reported symptoms, whereas no significant differences were observed for AstraZeneca (ChAdOx1 nCoV-19) or Sinovac (CoronaVac). No significant differences were found between sexes. Conclusions Obesity was associated with increased COVID-19 symptom burden in this population-based study. COVID-19 vaccination was associated with fewer reported symptoms among individuals with elevated BMI. Specifically, those vaccinated with Pfizer-BioNTech and CanSinoBio vaccines showed significant associations with reduced symptom burden, whereas vaccines from AstraZeneca and Sinovac did not. These findings support the relevance of vaccination strategies in populations with a high prevalence of obesity and highlight the need to consider metabolic factors and vaccine type when evaluating COVID-19 clinical presentation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.